Table 2.

Study schedule.

Assessment/Case Report Form	Baseline	1 week post-treatment	3 months post-treatment	6 months post-treatment
Informed consent, collection of individual demographic and baseline characteristics, randomization	X
VPM (discourse speech samples)	X	X	X	X
WAB-R	X	X	X	X
SAQOL-39g	X	X	X	X
CETI	X	X	X
ASRS	X	X	X
PPTT	X
WAIS	X
PRT	X	X	X
PNT	X	X	X
Adverse Event	O	O	O	O

X = required; O = optional/repeatable.